Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
Study NCT ID:
NCT01001832
Status:
COMPLETED
Last Update Posted:
2014-02-06
First Post:
2009-10-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-26
First Submit QC Date:
None
Study First Post Date:
2009-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-10-22
Results First Submit QC Date:
None
Results First Post Date:
2013-02-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-02
Last Update Post Date:
2014-02-06
Last Update Post Date Type:
ESTIMATED